Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
11.18
-0.02 (-0.18%)
Dec 3, 2024, 12:09 PM EST - Market open
Kura Oncology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 49.48 | 37.32 | 51.8 | 90.67 | 325.49 | 26.14 | Upgrade
|
Short-Term Investments | 405.82 | 386.64 | 386.18 | 427.29 | 307.83 | 210.76 | Upgrade
|
Cash & Short-Term Investments | 455.3 | 423.96 | 437.99 | 517.96 | 633.32 | 236.89 | Upgrade
|
Cash Growth | 0.60% | -3.20% | -15.44% | -18.22% | 167.35% | 32.35% | Upgrade
|
Other Receivables | 4.7 | 3.9 | 0.9 | 1.4 | - | - | Upgrade
|
Receivables | 4.7 | 3.9 | 0.9 | 1.4 | - | - | Upgrade
|
Prepaid Expenses | 3.19 | 4.62 | 7.54 | 2.93 | 3.97 | 2.71 | Upgrade
|
Total Current Assets | 463.19 | 432.48 | 446.43 | 522.29 | 637.29 | 239.6 | Upgrade
|
Property, Plant & Equipment | 7.42 | 8.85 | 6.38 | 8.25 | 8.36 | 0.28 | Upgrade
|
Other Long-Term Assets | 8.23 | 7.6 | 3.5 | 3.52 | 1.57 | 2.09 | Upgrade
|
Total Assets | 478.84 | 448.94 | 456.31 | 534.05 | 647.21 | 241.97 | Upgrade
|
Accounts Payable | 3.01 | 2.3 | 1.53 | 3.24 | 2.75 | 3.53 | Upgrade
|
Accrued Expenses | 33.96 | 31.46 | 20.21 | 16.96 | 18.18 | 11.54 | Upgrade
|
Current Portion of Long-Term Debt | 1.72 | - | - | - | 3 | 0.25 | Upgrade
|
Current Portion of Leases | 1.69 | 1.51 | 2.32 | 2.26 | 2.09 | 0.25 | Upgrade
|
Total Current Liabilities | 40.37 | 35.26 | 24.06 | 22.46 | 26.02 | 15.56 | Upgrade
|
Long-Term Debt | 7.76 | 9.33 | 9.16 | - | 4.25 | 7.25 | Upgrade
|
Long-Term Leases | 5.47 | 6.36 | 2.55 | 4.61 | 5.64 | - | Upgrade
|
Other Long-Term Liabilities | 1.47 | 0.71 | 0.27 | 0.38 | 0.4 | 0.38 | Upgrade
|
Total Liabilities | 55.07 | 51.66 | 36.03 | 27.44 | 36.31 | 23.19 | Upgrade
|
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
Additional Paid-In Capital | 1,299 | 1,120 | 997.11 | 941.36 | 913.35 | 431.32 | Upgrade
|
Retained Earnings | -876.21 | -721.44 | -568.81 | -432.97 | -302.5 | -212.88 | Upgrade
|
Comprehensive Income & Other | 1.12 | -1.27 | -8.03 | -1.79 | 0.05 | 0.33 | Upgrade
|
Shareholders' Equity | 423.77 | 397.27 | 420.28 | 506.61 | 610.91 | 218.78 | Upgrade
|
Total Liabilities & Equity | 478.84 | 448.94 | 456.31 | 534.05 | 647.21 | 241.97 | Upgrade
|
Total Debt | 16.63 | 17.2 | 14.02 | 6.88 | 14.98 | 7.75 | Upgrade
|
Net Cash (Debt) | 438.67 | 406.76 | 423.96 | 511.09 | 618.34 | 229.14 | Upgrade
|
Net Cash Growth | 0.80% | -4.06% | -17.05% | -17.35% | 169.85% | 33.62% | Upgrade
|
Net Cash Per Share | 5.24 | 5.55 | 6.33 | 7.70 | 11.65 | 5.46 | Upgrade
|
Filing Date Shares Outstanding | 77.76 | 76.14 | 68.44 | 66.61 | 66.21 | 45.43 | Upgrade
|
Total Common Shares Outstanding | 77.75 | 74.35 | 68.31 | 66.57 | 66.19 | 45.38 | Upgrade
|
Working Capital | 422.82 | 397.22 | 422.37 | 499.83 | 611.27 | 224.04 | Upgrade
|
Book Value Per Share | 5.45 | 5.34 | 6.15 | 7.61 | 9.23 | 4.82 | Upgrade
|
Tangible Book Value | 423.77 | 397.27 | 420.28 | 506.61 | 610.91 | 218.78 | Upgrade
|
Tangible Book Value Per Share | 5.45 | 5.34 | 6.15 | 7.61 | 9.23 | 4.82 | Upgrade
|
Machinery | 2.84 | 2.77 | 2.6 | 1.99 | 1.14 | 0.14 | Upgrade
|
Leasehold Improvements | 1.54 | 1.54 | 1.54 | 1.53 | 1.17 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.